As per attachment

Revenue growth above 20%EBITDA margin compressionRelated-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

—

prior close

₹122.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—

Garments & Apparels peers, median of 36sector-0.1%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+26.1

30m

+14.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.1—-0.1—

Next day

—+0.2—-0.1—

—+0.6—+0.0—

—+0.9—-0.3—

—+1.0—-0.3—

—+0.7—-1.6—

—+1.8—+0.0—

15d

—+1.7—-1.5—

—+3.1—+0.0—

—+1.7—-3.3—

—-1.0—-7.6—

UpDownMarket · Nifty Microcap 250Sector · Garments & Apparels peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Spenta International Limited, a textile (hosiery/socks) company, reported FY25 revenue from operations of ₹4,763.84 lakhs, up about 35.5% from ₹3,514.68 lakhs in FY24. Profit after tax rose to ₹121.49 lakhs (FY24: ₹110.12 lakhs), a modest 10.3% increase, with EPS at ₹4.39 vs ₹3.98. Q4 FY25 was weaker on a sequential and yearly basis — PAT fell to ₹12.99 lakhs versus ₹47.76 lakhs in Q4 FY24, even as quarterly revenue grew to ₹982.83 lakhs. The board has recommended a dividend of ₹1.00 per share (face value ₹10). The statutory auditor (A K Kochar & Associates) issued an unmodified/unqualified opinion on the results. Operating cash flow remained healthy at ₹346.79 lakhs (FY24: ₹311.88 lakhs), and long-term borrowings reduced to ₹310.90 lakhs from ₹405.50 lakhs.

Likely market impact

Strong top-line growth on a full-year basis is positive, but the sharp drop in Q4 profit and an EBITDA margin compression (roughly 11.6% to 9.1%) suggest rising costs or weaker Q4 pricing. Small-cap investors should weigh the healthy dividend and debt reduction against weak Q4 profitability and modest PAT growth.